Savita Lochab

Title: Savita Lochab: Innovator in Anti-Leukemic Research

Introduction

Savita Lochab is a notable inventor based in Lucknow, India. She has made significant contributions to the field of medical research, particularly in the development of anti-leukemic agents. Her work focuses on inducing differentiation in myeloid leukemia cells, which is crucial for advancing treatment options for this type of cancer.

Latest Patents

Savita Lochab holds a patent for an anti-leukemic agent that is useful for inducing differentiation in myeloid leukemia cells. The patent describes the compound Ormeloxifene, which is effective in treating various forms of myeloid leukemia, including acute promyelocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The invention highlights how Ormeloxifene induces differentiation, marked by an increase in differentiation marker proteins and surface proteins. The research indicates that differentiated cells exhibit neutrophil-like morphology when treated with specific doses of Ormeloxifene, demonstrating its potential as a therapeutic agent.

Career Highlights

Savita Lochab is affiliated with the Council of Scientific and Industrial Research, where she conducts her research. Her innovative work has led to advancements in understanding how to combat myeloid leukemia through differentiation induction. She has successfully developed a compound that shows promise in improving treatment outcomes for patients suffering from this disease.

Collaborations

Savita has collaborated with colleagues such as Pooja Pal and Sabyasachi Sanyal, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Savita Lochab's contributions to anti-leukemic research exemplify the impact of innovative thinking in the medical field. Her patent for Ormeloxifene represents a significant step forward in the treatment of myeloid leukemia, showcasing her dedication to improving patient outcomes.